Intrinsic Value of S&P & Nasdaq Contact Us

Delcath Systems, Inc. DCTH NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
66/100
4/7 Pass
SharesGrow Intrinsic Value
$12.42
+13%
Analyst Price Target
$24.00
+118.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Delcath Systems, Inc. (DCTH) trades at a trailing P/E of 132.1, forward P/E of 65.8. Trailing earnings yield is 0.76%, forward earnings yield 1.52%. PEG 0.45 (Peter Lynch undervalued ≤1.0). Graham Number is $2.26.

Criteria proven by this page:

  • VALUE (74/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.45); analyst target implies upside (+118.4%).
  • Forward P/E 65.8 (down from trailing 132.1) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.45 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.76% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.52% as earnings recover.
  • Analyst consensus target $24.00 (+118.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 66/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
66/100
SG Score
View full scorecard →
VALUE
74/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
100/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — DCTH

Valuation Multiples
P/E (TTM)132.1
Forward P/E65.8
PEG Ratio0.45
Forward PEG0.45
P/B Ratio3.21
P/S Ratio3.99
EV/EBITDA115.8
Per Share Data
EPS (TTM)$0.07
Forward EPS (Est.)$0.17
Book Value / Share$3.05
Revenue / Share$2.34
FCF / Share$0.58
Yields & Fair Value
Earnings Yield0.76%
Forward Earnings Yield1.52%
Dividend Yield0.00%
Graham Number$2.26
SharesGrow IV$12.42 (+13%)
Analyst Target$24.00 (+118.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 0.0 0.00 0.00 0.00 -
2017 0.0 0.00 0.03 0.01 2,777.91%
2018 -0.4 0.00 -0.50 2.19 -
2019 -0.1 0.00 -0.09 0.35 -
2020 -2.1 0.02 2.35 31.55 -
2021 -2.2 0.04 4.63 15.58 -
2022 -0.9 -0.06 -5.45 11.74 -
2023 -1.4 0.05 4.28 32.70 -
2024 -13.0 0.19 4.99 9.23 -
2025 134.0 -1.24 3.25 4.24 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-781,348.00 $1.99M $-17.97M -902.2%
2017 $-138,822.00 $2.72M $-45.12M -1661.8%
2018 $-503.84 $3.41M $-19.22M -564.2%
2019 $-526.14 $1.58M $-13.63M -862.5%
2020 $-8.45 $1.65M $-24.49M -1487.5%
2021 $-3.74 $3.56M $-26.76M -752.7%
2022 $-4.42 $2.72M $-39.16M -1440.3%
2023 $-2.94 $2.07M $-47.68M -2308.9%
2024 $-0.93 $37.21M $-26.39M -70.9%
2025 $0.07 $85.23M $2.7M 3.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.60 $-0.66 – $-0.57 $104.08M $99.89M – $111.31M 4
2027 $-0.20 $-0.21 – $-0.19 $138.57M $132.99M – $148.2M 4
2028 $0.34 $-0.92 – $2.00 $168.17M $167.25M – $169.09M 5
2029 $0.69 $0.65 – $0.75 $194.01M $186.2M – $207.49M 1
2030 $1.29 $1.22 – $1.40 $226.32M $217.2M – $242.04M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message